Abstract
A small molecule containing a rhodium(II) tetracarboxylate fragment is shown to be a potent inhibitor of the prolyl isomerase FKBP12. The use of small molecules conjugates of rhodium(II) is presented as a general strategy for developing new protein inhibitors based on distinct structural and sequence features of the enzyme active site.
Keywords:
Enzyme inhibition; FKBP; Metallodrug; Prolyl isomerase; Rhodium.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacology
-
Peptidylprolyl Isomerase / antagonists & inhibitors
-
Peptidylprolyl Isomerase / metabolism
-
Protein Structure, Tertiary
-
Rhodium / chemistry*
-
Rhodium / pharmacology
-
Tacrolimus Binding Protein 1A / antagonists & inhibitors*
-
Tacrolimus Binding Protein 1A / metabolism
Substances
-
Enzyme Inhibitors
-
Rhodium
-
Tacrolimus Binding Protein 1A
-
Peptidylprolyl Isomerase